These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 23879434)

  • 101. Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier.
    Shu LZ; Ding YD; Xue QM; Cai W; Deng H
    Therap Adv Gastroenterol; 2023; 16():17562848231176427. PubMed ID: 37274298
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The intestinal barrier: a fundamental role in health and disease.
    Vancamelbeke M; Vermeire S
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):821-834. PubMed ID: 28650209
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Paneth cell: The missing link between obesity, MASH and portal hypertension.
    Kumar MS
    Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102259. PubMed ID: 38070827
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
    Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Shirokova E
    World J Clin Cases; 2021 Nov; 9(31):9320-9332. PubMed ID: 34877269
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Current progress of research on intestinal bacterial translocation.
    Wang YH
    Microb Pathog; 2021 Mar; 152():104652. PubMed ID: 33249165
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The heart and the gut.
    Rogler G; Rosano G
    Eur Heart J; 2014 Feb; 35(7):426-30. PubMed ID: 23864132
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis.
    Bloom PP; Rao K; Bassis CM; Zhou SY; Nojkov B; Owyang C; Young VB; Lok AS
    Clin Transl Gastroenterol; 2022 Oct; 13(10):e00522. PubMed ID: 36000993
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Gut barrier dysfunction in obstructive jaundice. The Purce Lecture 1997.
    Parks R
    Ulster Med J; 1998 Jun; 67 Suppl 1(Suppl 1):86-90. PubMed ID: 9807963
    [No Abstract]   [Full Text] [Related]  

  • 109. The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations.
    Assimakopoulos SF; Bhagani S; Aggeletopoulou I; Tsounis EP; Tsochatzis EA
    Infection; 2024 Jun; 52(3):723-736. PubMed ID: 38324146
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Probiotics in liver diseases].
    Soriano G; Sánchez E; Guarner C
    Nutr Hosp; 2013; 28(3):558-63. PubMed ID: 23848072
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut-Liver Axis.
    Dumitru A; Matei E; Cozaru GC; Chisoi A; Alexandrescu L; Popescu RC; Butcaru MP; Dumitru E; Rugină S; Tocia C
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473721
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Intestinal barrier dysfunction following traumatic brain injury.
    Pan P; Song Y; Du X; Bai L; Hua X; Xiao Y; Yu X
    Neurol Sci; 2019 Jun; 40(6):1105-1110. PubMed ID: 30771023
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Liver cirrhosis and complications from the perspective of dysbiosis.
    Nie G; Zhang H; Xie D; Yan J; Li X
    Front Med (Lausanne); 2023; 10():1320015. PubMed ID: 38293307
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation.
    Palma P; Mihaljevic N; Hasenberg T; Keese M; Koeppel TA
    Hepatol Res; 2007 Jan; 37(1):6-12. PubMed ID: 17300693
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Bacterial translocation and change in intestinal permeability in patients after abdominal surgery.
    Qiao Z; Li Z; Li J; Lu L; Lv Y; Li J
    J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):486-91. PubMed ID: 19662368
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Novel perspectives in the management of decompensated cirrhosis.
    Bernardi M; Caraceni P
    Nat Rev Gastroenterol Hepatol; 2018 Dec; 15(12):753-764. PubMed ID: 30026556
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants.
    Albillos A; de la Hera A
    J Hepatol; 2002 Oct; 37(4):523-6. PubMed ID: 12217607
    [No Abstract]   [Full Text] [Related]  

  • 118. Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis?
    Vlachogiannakos J; Daikos G; Thalheimer U; Burroughs AK; Ladas SD
    Hepatology; 2011 Jun; 53(6):2140-1; author reply 41-2. PubMed ID: 21425309
    [No Abstract]   [Full Text] [Related]  

  • 119. Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteria.
    Bloom PP; Rao K; Bassis C; Nojkov B; Young VB; Lok AS
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756036
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Intestinal barrier dysfunction in severe burn injury.
    He W; Wang Y; Wang P; Wang F
    Burns Trauma; 2019; 7():24. PubMed ID: 31372365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.